The pharmaceutical industry operates in the production of medicines, thus ensuring the health of the population. Given the importance of this industrial sector, biosafety practices become fundamental.
This is because the manufacture of drugs involves risks for workers, users and the community in general.
Want to better understand how the biosafety practices in the pharmaceutical industry? This text will approach the subject in a simple and complete way. Keep reading.
You will find
What is biosecurity?
Biosafety has as its main objective ensure that scientific procedures are safe. She seeks strategies to control, reduce or even eliminate risks involved in activities related to science and health.
Different sectors of society, such as laboratories, hospitals, research centers, among others, must adopt biosafety practices. This means that these spaces must ensure that their activities do not pose risks to people, animals and the environment.
Risk rating
To deepen the debate on biosafety, it is necessary to understand the risk rating. There are four levels for classifying microorganisms according to the greater or lesser risk they pose.
Briefly, these four biosafety levels are organized as follows:
- Risk 1 – microorganisms that offer very low or non-existent individual or community risk;
- risk 2 – microorganisms that offer low risk in the community, but moderate individually;
- risk 3 – microorganisms that offer limited community risk, but high individually;
- Risk 4 – microorganisms that offer high individual or community risk.
The Importance of Biosafety in the Pharmaceutical Industry
Understanding what biosafety is, its connection with the pharmaceutical industry becomes evident. Inadequate practices can result in environmental contamination, spread of disease, worker infections and other possible harm.
Therefore, biosafety processes in the pharmaceutical industry require care when handling chemicals, strict production control and environmental cleaning procedures.
Cleaning, sanitization and disinfection: good practices
Good biosafety practices in the pharmaceutical industry can be categorized into three areas: cleaning, sanitization and disinfection. Although they may seem similar, each one has its own characteristics.
Cleaning in the pharmaceutical industry consists of the efficient removal of dirt present on the surfaces of spaces. Its objective is to periodic removal of microorganisms present in spaces.
Sanitization follows health surveillance guidelines, using specific products to remove agents harmful to health.
Disinfection also uses specific products, known as disinfectants, to eliminate viruses and bacteria by up to 99%.
About Asmotec
To ensure an environment suitable for biosafety practices, It is essential to have experts on the subject. In this context, Asmontec is a leading partner in promoting biosafety in the pharmaceutical industry and other sectors.
With over 27 years of experience, We are the first and only ISO9001 certified cleanroom engineering company. A reference in the cleanroom market, we show commitment to safety and health in critical environments.
In a market where negligence is a growing problem, Asmontec stands out as a leader committed to ensuring safety and health, demonstrating that biosafety is an essential value in the pharmaceutical industry.
